IMMUNOVANT SCIENCES HOLDINGS LIMITED

11460737
Active London

Activities of other holding companies n.e.c.

2 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
I

IMMUNOVANT SCIENCES HOLDINGS LIMITED

11460737

Activities of other holding companies n.e.c.

Founded 12 Jul 2018 Active London, United Kingdom 2 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
Accounts Submitted 6 Jan 2026 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 11 Jul 2025 Next due 25 Jul 2026 26 days remaining
Net assets £-60K £65K 2024 year on year
Total assets £20K £5K 2024 year on year
Total Liabilities £80K £60K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

7th Floor 50 Broadway London SW1H 0DB United Kingdom

Website

www.example.com

Full company profile for IMMUNOVANT SCIENCES HOLDINGS LIMITED (11460737), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 12 Jul 2018. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type full
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Net Assets, Total Assets & Total Liabilities (2018–2024)

Cash in Bank

N/A

Net Assets

-£59.55k

Decreased by £64.56k (-1288%)

Total Liabilities

£79.90k

Increased by £59.87k (+299%)

Turnover

N/A

Employees

2

Debt Ratio

393%

Increased by 313 (+391%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2023
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 3 Shares £445k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Dec 20251$340k$340k
30 Mar 20201$30k$30k
29 Mar 20191$75k$75k

Officers

Officers

2 active 1 resigned
Status
Moore, Lee FrancisDirectorBritishUnited Kingdom4512 Jul 2018Active
Vistra Cosec LimitedCorporate-secretaryUnknownUnknown12 Jul 2018Active

Shareholders

Shareholders (1)

Immunovant Sciences Ltd.
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Immunovant, Inc.

United States Of America

Active
Notified 19 Dec 2019
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

IMMUNOVANT SCIENCES HOLDINGS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Apr 2026OfficersChange to director Mr Lee Francis Moore on 2 Mar 2026
31 Mar 2026OfficersChange Corporate Secretary Company With Change Date
6 Jan 2026AccountsAnnual accounts made up to 31 Mar 2025
31 Dec 2025CapitalAllotment of shares (USD 20,563) on 30 Dec 2025
11 Jul 2025Confirmation StatementConfirmation statement made on 11 Jul 2025 with no updates
27 Apr 2026 Officers

Change to director Mr Lee Francis Moore on 2 Mar 2026

31 Mar 2026 Officers

Change Corporate Secretary Company With Change Date

6 Jan 2026 Accounts

Annual accounts made up to 31 Mar 2025

31 Dec 2025 Capital

Allotment of shares (USD 20,563) on 30 Dec 2025

11 Jul 2025 Confirmation Statement

Confirmation statement made on 11 Jul 2025 with no updates

Recent Activity

Latest Activity

Change to director Mr Lee Francis Moore on 2 Mar 2026

2 months ago on 27 Apr 2026

Change Corporate Secretary Company With Change Date

2 months ago on 31 Mar 2026

Annual accounts made up to 31 Mar 2025

5 months ago on 6 Jan 2026

Allotment of shares (USD 20,563) on 30 Dec 2025

5 months ago on 31 Dec 2025

Confirmation statement made on 11 Jul 2025 with no updates

11 months ago on 11 Jul 2025